These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7060628)

  • 1. The effect of diltiazem on coronary thrombosis in the conscious canine.
    Shea MJ; Bush LR; Romson JL; Driscoll EM; Lucchesi BR
    Eur J Pharmacol; 1982 Jan; 77(1):67-70. PubMed ID: 7060628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diltiazem reduced infarct size but not ventricular arrhythmias in 48 hour coronary embolized dogs.
    Yoshida S; Downey JM; Yellon DM; Miura T; Iimura O
    Can J Cardiol; 1985; 1(5):346-53. PubMed ID: 3842096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia.
    Fiedler VB
    Basic Res Cardiol; 1983; 78(3):266-80. PubMed ID: 6615399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs.
    Bush LR; Buja LM; Tilton G; Wathen M; Apprill P; Ashton J; Willerson JT
    Circulation; 1985 Aug; 72(2):413-30. PubMed ID: 4006149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zomepirac on experimental coronary artery thrombosis and ischemic myocardial injury in the conscious dog.
    Hook BG; Romson JL; Jolly SR; Bailie MB; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(2):302-8. PubMed ID: 6188907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diltiazem upon experimental ventricular dysrhythmias.
    Patterson E; Eller BT; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a calcium-entry blocker (diltiazem) on regional myocardial flow and function during exercise in conscious dogs.
    Matsuzaki M; Gallagher KP; Patritti J; Tajimi T; Kemper WS; White FC; Ross J
    Circulation; 1984 Apr; 69(4):801-14. PubMed ID: 6697464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diltiazem on vulnerability to atrial and ventricular reentrant arrhythmias in the normal and ischemic heart.
    Heuer H; Gülker H; Thale J; Meyer M; Weiss U; Bendeer F
    Arzneimittelforschung; 1983; 33(8):1113-6. PubMed ID: 6685488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.
    Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR
    Eur J Pharmacol; 1984 Oct; 105(3-4):285-91. PubMed ID: 6542526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of diltiazem in the treatment of acute myocardial infarct].
    Milazzotto F; Citone C; Tubaro M
    Cardiologia; 1985 Feb; 30 Suppl 2():37-42. PubMed ID: 3830396
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of diltiazem on pacing-inducing ischemia in conscious dogs with coronary stenosis: improvement of postpacing deterioration of ischemic myocardial function.
    Sasayama S; Takahashi M; Nakamura M; Ohyagi A; Yamamoto A; Shimada T; Kawai C
    Am J Cardiol; 1981 Sep; 48(3):460-7. PubMed ID: 7270452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of diltiazem on experimental coronary artery thrombosis in dogs.
    Schumacher WA; Lucchesi BR
    Pharmacology; 1990; 41(1):16-23. PubMed ID: 2236203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart.
    Ichihara K; Abiko Y
    J Pharmacol Exp Ther; 1982 Sep; 222(3):720-5. PubMed ID: 6286933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diltiazem on experimental myocardial ischemia and on left ventricular performance.
    Clozel JP; Théroux P; Bourassa MG
    Circ Res; 1983 Feb; 52(2 Pt 2):I120-8. PubMed ID: 6831646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist.
    Lucchessi BR; Rote WE; Driscoll EM; Mu DX
    Br J Pharmacol; 1994 Dec; 113(4):1333-43. PubMed ID: 7889289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
    Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diltiazem on cardiac function and regional blood flow at rest and during exercise in a conscious rat preparation of chronic heart failure (myocardial infarction).
    Drexler H; Depenbusch JW; Truog AG; Zelis R; Flaim SF
    Circulation; 1985 Jun; 71(6):1262-70. PubMed ID: 3995715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of aspirin and diltiazem to prevent the formation of acute coronary thrombi in dogs.
    Morishima Y; Tanaka T; Watanabe K; Shibutani T; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):273-7. PubMed ID: 7475514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.
    Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR
    Am Heart J; 1984 Apr; 107(4):629-37. PubMed ID: 6702555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.